These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17053580)

  • 1. The role of right ventricular-pulmonary arterial coupling to differentiate between effects of inotropic agents in experimental right heart failure.
    Lambermont B; D'Orio V
    Crit Care Med; 2006 Nov; 34(11):2864-5. PubMed ID: 17053580
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
    Kerbaul F; Rondelet B; Demester JP; Fesler P; Huez S; Naeije R; Brimioulle S
    Crit Care Med; 2006 Nov; 34(11):2814-9. PubMed ID: 16971854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction.
    Missant C; Rex S; Segers P; Wouters PF
    Crit Care Med; 2007 Mar; 35(3):707-15. PubMed ID: 17255859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
    Kerbaul F; Gariboldi V; Giorgi R; Mekkaoui C; Guieu R; Fesler P; Gouin F; Brimioulle S; Collart F
    Crit Care Med; 2007 Aug; 35(8):1948-54. PubMed ID: 17568324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension.
    Adie SK; Abdul-Aziz AA; Ketcham SW; Moles VM
    J Cardiovasc Pharmacol; 2022 Jan; 79(1):e11-e17. PubMed ID: 34654789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of levosimendan in patients with predominant right heart failure.
    Poelzl G; Zwick RH; Grander W; Metzler B; Jonetzko P; Frick M; Ulmer H; Pachinger O; Roithinger FX
    Herz; 2008 Jul; 33(5):368-73. PubMed ID: 18773157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights for the diagnosis and management of right ventricular failure, from molecular imaging to targeted right ventricular therapy.
    Haddad F; Ashley E; Michelakis ED
    Curr Opin Cardiol; 2010 Mar; 25(2):131-40. PubMed ID: 20130456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
    Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
    Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right ventricular failure after cardiac surgery: management strategies.
    Itagaki S; Hosseinian L; Varghese R
    Semin Thorac Cardiovasc Surg; 2012; 24(3):188-94. PubMed ID: 23200073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.
    Haddad F; Doyle R; Murphy DJ; Hunt SA
    Circulation; 2008 Apr; 117(13):1717-31. PubMed ID: 18378625
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inotropic treatment in heart transplantation].
    Giordano F; Muzzi R
    Minerva Anestesiol; 1992 Oct; 58(10):657-64. PubMed ID: 1461438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular dysfunction.
    Woods J; Monteiro P; Rhodes A
    Curr Opin Crit Care; 2007 Oct; 13(5):532-40. PubMed ID: 17762232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular dysfunction in chronic heart failure.
    Giannakoulas G; Parcharidou D; Efthimiadis G; Karvounis H; Styliadis I; Parcharidis G
    Am J Cardiol; 2008 Apr; 101(7):1070. PubMed ID: 18359338
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodynamic properties of a new-generation positive luso-inotropic agent for the acute treatment of advanced heart failure.
    Sabbah HN; Imai M; Cowart D; Amato A; Carminati P; Gheorghiade M
    Am J Cardiol; 2007 Jan; 99(2A):41A-46A. PubMed ID: 17239704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
    Reddy MT; Patel H; Ventura HO
    Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.
    Haddad F; Hunt SA; Rosenthal DN; Murphy DJ
    Circulation; 2008 Mar; 117(11):1436-48. PubMed ID: 18347220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.